Brief: Arjo Starts Randomized Controlled Trial For Wound Care Treatment

Arjo AB (publ)

27/02/2020 07:09

Feb 27 (Reuters) - Arjo AB (publ)  ARJOb.ST :
    * ARJO INITIATES A RANDOMIZED CONTROLLED TRIAL FOR WOUND
CARE
TREATMENT AFTER STRONG EVALUATION RESULTS
    * WILL TODAY PUBLISH RESULTS FROM A HIGHLY SUCCESSFUL
MULTI-CENTRE
CLINICAL EVALUATION FOR RECENTLY LAUNCHED WOUNDEXPRESS™
    * EVALUATION IS SHOWING HIGHLY PROMISING RESULTS
    * IN OVER 95% OF CASES, SIGNIFICANT IMPROVEMENT WAS SEEN IN
WOUND
HEALING AND IN A THIRD OF CASES, WOUNDS HEALED ENTIRELY.
    * FURTHER, OVER 95% OF PATIENTS REPORTED SIGNIFICANT
REDUCTION OF
PAIN AND INCREASED QUALITY OF LIFE

Source text for Eikon:  ID:nWkr8SNyPd 
Further company coverage:  ARJOb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))